Figure 2.

SIRT1 and SIRT5 deacetylate and interact with PML. (a and b) HeLa cells were transfected with HA-PML4 and Myc-SIRT1 (wild-type or H363Y mutant (a)) or FLAG-SIRT5 (wild-type or H158Y mutant (b)). Whole-cell extracts (WCEs) were prepared and analyzed by immunoblotting with anti-HA and anti-Myc or anti-FLAG antibodies (upper panels). The WCEs were analyzed by immunoprecipitation with anti-HA antibody followed by immunoblotting with anti-acetyl-lysine and anti-HA or anti-FLAG antibodies (lower panels). (c and d) HeLa cells stably expressing indicated shRNA were transfected with HA-PML4. WCEs were analyzed by immunoblotting with indicated antibodies (upper panels) and by immunoprecipitation with anti-HA antibody followed by immunoblotting with anti-acetyl-lysine and anti-HA antibodies (lower panels). (e) WCEs of HeLa cells stably expressing indicated shRNAs were analyzed by immunoblotting with indicated antibodies (upper panels) and by immunoprecipitation with anti-PML antibody followed by immunoblotting with anti-acetyl-lysine and anti-PML antibodies. (f and h) HeLa cells stably expressing SIRT1 (f) or SIRT5 (h) shRNA were grown, harvested, and analyzed by immunoblotting with indicated antibodies (upper panels) and by immunoprecipitation with indicated antibodies followed by immunoblotting with indicated antibodies. (g and i) HeLa cells were transfected with HA-PML4 and with or without FLAG-SIRT1 (g) or FLAG-SIRT5 (i). WCEs were prepared and immunoprecipitated with anti-FLAG antibodies followed by immunoblotting with indicated antibodies